TMCnet - World's Largest Communications and Technology Community



Uveitis Forecast in 18 Major Markets 2018-2028: Data Split by Gender and 5 Year Age Cohort -
[March 09, 2018]

Uveitis Forecast in 18 Major Markets 2018-2028: Data Split by Gender and 5 Year Age Cohort -

The "Epiomic Epidemilogy Series: Uveitis Forecast in 18 Major Markets 2018-2028" report has been added to's offering.

This report covers uveitis of immune and infectious origin, while excluding traumatic and post-operative uveitis, as well as Fuchs' heterochromic iridocyclitis.

Uveitis is a general term denoting a group of inflammatory conditions of the eye. It affects mainly the uvea, a structure comprising the iris, ciliary body and choroid, but it can also affect nearby structures within the eye: the retina, vitreous humour and optic nerve. The condition constitutes a major cause of vision loss and blindness worldwide, but is thought to receive insufficient attention of healthcare professionals not specialised in ophthalmology.

This report provides the current prevalent population for uveitis across 18 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the author's analysis team, uveitis categories based on location and aetiology, several features of uveitis patients, as wellas the main comorbidities of the disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of uveitis include:

  • Autoimmune diseases (systemic)
  • Ocular hypertension
  • Macular oedema
  • Epiretinal membrane
  • Diabetes mellitus
  • Tuberculosis and other infections

Reason to buy

  • Ability to quantify patient populations in global uveitis market to target the development of future products, pricing strategies and launch plans.
  • Further insight into the prevalence of the subdivided types of uveitis and identification of patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Better understanding of the impact of specific co-morbid conditions on the prevalent population of uveitis patients.
  • Identification of uveitis patient sub-populations that require treatment.
  • Better understanding of the specific markets that have the largest number of uveitis patients.

Key Topics Covered:

  1. Introduction
  2. Cause Of The Disease
  3. Risk Factors & Prevention
  4. Diagnosis Of The Disease
  5. Variation By Geography/Ethnicity
  6. Disease Prognosis (News - Alert) & Clinical Course
  7. Standardisation Of Uveitis Nomenclature (Sun) Working Group Guidelines
  8. Key Comorbid Conditions / Features Associated With The Disease
  9. Methodology For Quantification Of Patient Numbers
  10. Top-Line Prevalence For Uveitis
  11. Features Of Uveitis Patients
  12. Aetiology Of Uveitis
  13. Infectious Causes Of Uveitis
  14. Autoimmune Causes Of Uveitis
  15. Vision Loss In Uveitis
  16. Comorbid Ophthalmic Conditions In Uveitis
  17. Abbreviations Used In The Report
  18. Reports & Publications
  19. Online Epidemiology Databases
  20. Online Pharmaceutical Pricing Database
  21. References
  22. Appendix

For more information about this report visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy